A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis
1. 系统已在2025-06-23 09:34:14对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.kint.2024.02.024
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0085253824001960
其他信息:
出版社: Elsevier BV
作者: Wolfgang C. Winkelmayer; Anthonie W.A. Lensing; Ravi I. Thadhani; Kenneth W. Mahaffey; Michael Walsh; Ákos F. Pap; Stefan Willmann; Kirstin Thelen; Sophie Hodge; Alexander Solms; Sheila J.M. Ingham; John Eikelboom